Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Jul. 31, 2019
Jul. 31, 2018
Research and Development Expense [Member]        
Non-cash share-based compensation expenses $ 338,449 $ 2,472,489 $ 2,567,294 $ 2,668,315
Selling, General and Administrative Expenses [Member]        
Non-cash share-based compensation expenses $ 492,449 $ 2,155,844 $ 2,335,218 $ 2,558,701